Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer-Reference-Cited by-同舟云学术

Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer

Published:2008-10 Issue:10 Volume:10 Page:646-653
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Sánchez-Muñoz Alfonso,García-Tapiador Ana María,Martínez-Ortega Esther,Dueñas-García Rosario,Jaén-Morago Ana,Ortega-Granados Ana Laura,Fernández-Navarro Mónica,de la Torre-Cabrera Capilla,Dueñas Basilio,Rueda Ana Isabel,Morales Francisco,Ramírez-Torosa César,Martín-Salvago María Dolores,Sánchez-Rovira Pedro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-008-0265-y.pdf

Reference46 articles.

1. Jensen OM, Esteve J, Moller H et al (1990) Cancer in the European community and its member states. Eur J Cancer 26:1167–1256

2. American Cancer Society (1995) Cancer facts and figures. National Media Office, New York, NY [Brochure]

3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717

4. Harris JR, Marrow M, Bonadonna G (1993) Cancer of the breast. In Devita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 4th Edn. Lippincott, Philadelphia, PA, pp 1264–1332

5. Mouridsen HT (1992) Systemic therapy of advanced breast cancer. Drugs 44:17–28

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer;International Journal of Molecular Sciences;2023-09-30

2. Triple-negative breast cancer on contrast-enhanced MRI and synthetic MRI: A comparison with non-triple-negative breast carcinoma;European Journal of Radiology;2021-09

3. Prediction of Invasive Breast Cancer Using Mass Characteristic Frequency and Elasticity in Correlation with Prognostic Histologic Features and Immunohistochemical Biomarkers;Ultrasound in Medicine & Biology;2021-08

4. Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial;BMC Cancer;2021-01-11

5. BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score;BMC Clinical Pathology;2018-12